Form 4: Bio-Techne Corp Director Joseph D. Keegan Reports Acquisition of Common Stock and Stock Options

Director Joseph D. Keegan reports acquiring common stock and stock options in Bio-Techne Corp on October 24, 2024.

Summary

• On October 24, 2024, Joseph D. Keegan, a director of Bio-Techne Corp, reported acquiring 1,462 shares of common stock at $0 price.
• Following this transaction, Keegan directly owns 13,771 shares of common stock.
• Keegan also acquired 3,511 stock options with an exercise price of $68.37, exercisable starting October 24, 2024, and expiring on October 24, 2034.
• The vesting of these options occurs on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's 2025 annual meeting of shareholders.
• Keegan also holds various other stock options with different exercise prices and expiration dates.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option acquisitions by a company director. The acquisition itself could be seen as a slightly positive signal.

Positives

• The director's acquisition of shares and options may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The director's stock acquisition could positively influence shareholder sentiment.

Key Dates